Jennifer M Jackson-allen, | |
147 Stratmore Pl, Stockbridge, GA 30281-1083 | |
(770) 714-6713 | |
Not Available |
Full Name | Jennifer M Jackson-allen |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 147 Stratmore Pl, Stockbridge, Georgia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043705262 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TS0200X | Psychologist - School | (Georgia) | Secondary |
101YP2500X | Counselor - Professional | LPC008858 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jennifer M Jackson-allen, 147 Stratmore Place, Stockbridge, GA 30281-1083 Ph: (770) 714-6713 | Jennifer M Jackson-allen, 147 Stratmore Pl, Stockbridge, GA 30281-1083 Ph: (770) 714-6713 |
News Archive
California Gov. Arnold Schwarzenegger is planning cuts to health programs and has "warned more would come if the federal government does not increase program reimbursements," ModernHealthcare reports. "His $82.9 billion spending plan for fiscal 2010-11 includes $750 million in cuts to Medi-Cal, the state's Medicaid program. Prison medical care would be cut by $811 million under his plan." Schwarzenegger is seeking $1.8 billion more in Medicaid funds by raising California's match to the national average for the program — 57 percent (Vesely, 1/8).
The FDA on Monday said it's entering into a collaboration with the nonprofit group PATH "to speed creation of a pneumococcal vaccine for children in developing nations," United Press International reports (2/1).
One hundred invited health and policy leaders will meet again in Washington, D.C. on June 29-30 to identify targeted strategies for establishing a national breastfeeding agenda as part of our nation's Health Reform, building on the essential recommendations and positive outcomes of the Second Annual Summit held last June.
Johns Hopkins scientists and their colleagues paired laboratory and epidemiologic data to find that men using the cardiac drug, digoxin, had a 24 percent lower risk for prostate cancer. The scientists say further research about the discovery may lead to use of the drug, or new ones that work the same way, to treat the cancer.
› Verified 2 days ago